Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Daesang Corporation is a prominent player in the food and chemical industries, primarily known for its extensive range of food products and ingredients. The company focuses on the production and distribution of fermented food products, spices, and condiments, including traditional Korean favorites like soy sauce and kimchi. Additionally, Daesang manufactures health foods and food ingredients, serving both domestic and international markets. Beyond food, the corporation has made significant inroads into the chemical sector, producing amino acids and other raw materials crucial for various industrial applications. Merging traditional culinary expertise with cutting-edge chemical innovation, Daesang Corporation plays a vital role in the global food supply chain and industrial chemical markets. The firm’s integrated approach to manufacturing and its commitment to quality place it as a key contributor to sustainable and efficient production methods, supporting both local cultures and international consumers. Headquartered in South Korea, Daesang Corporation continues to leverage its deep cultural heritage and industry knowledge to expand its influence and ensure product excellence across the globe.
€17,740.00
+€400.00 (+2.31%)
Live · 05:25 PM
Operating margin is thin at 3.85%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 3.4%, steady but not accelerating.
Net debt of ₩763.78B represents 16.2x FCF, leverage limits flexibility.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
₩4.38T
▲ +3.4% YoY
Net Income (TTM)
-₩298.89B
▼ -413.5% YoY
Op. Margin
3.86%
▼ -0.3pp YoY
ROIC
4.92%
Cash Flow & Balance Sheet
FCF (TTM)
₩76.41B
▲ +29.6% YoY
Op. Cash Flow (TTM)
₩236.62B
▼ -31.9% YoY
Net Debt
₩763.78B
Cash & Equiv.
₩653.25B
3Y CAGR: +2.5%
Continue Research
Daesang (001680.XKRX) trades above a two-stage DCF intrinsic value of about KRW 15,561.75 per share, so at KRW 17,740.00 the stock looks overvalued (12.3% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Daesang scores 25/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about KRW 15,561.75 per share for 001680.XKRX, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around KRW 11,671.32. At today's KRW 17,740.00, that puts the stock about 12.3% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Daesang scores 25 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 3.9% operating margin and a 4.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. 001680.XKRX currently trades above its estimated intrinsic value and scores 25/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.